BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 1955122)

  • 1. Cisapride in children with chronic intestinal pseudoobstruction. An acute, double-blind, crossover, placebo-controlled trial.
    Di Lorenzo C; Reddy SN; Villanueva-Meyer J; Mena I; Martin S; Hyman PE
    Gastroenterology; 1991 Dec; 101(6):1564-70. PubMed ID: 1955122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cisapride on antroduodenal motor function in healthy subjects and diabetics with autonomic neuropathy.
    Wehrmann T; Lembcke B; Caspary WF
    Aliment Pharmacol Ther; 1991 Dec; 5(6):599-608. PubMed ID: 1782304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.
    Camilleri M; Malagelada JR; Abell TL; Brown ML; Hench V; Zinsmeister AR
    Gastroenterology; 1989 Mar; 96(3):704-12. PubMed ID: 2644150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.
    Fraser RJ; Horowitz M; Maddox AF; Dent J
    Gut; 1994 Feb; 35(2):172-8. PubMed ID: 8307466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antroduodenal motility in children with chronic intestinal pseudo-obstruction.
    Hyman PE; McDiarmid SV; Napolitano J; Abrams CE; Tomomasa T
    J Pediatr; 1988 Jun; 112(6):899-905. PubMed ID: 3373394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cisapride and metoclopramide on human digestive and interdigestive antroduodenal motility.
    Lux G; Katschinski M; Ludwig S; Lederer P; Ellermann A; Domschke W
    Scand J Gastroenterol; 1994 Dec; 29(12):1105-10. PubMed ID: 7886398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effects of cisapride on gastric emptying and antropyloroduodenal motility.
    Fraser R; Horowitz M; Maddox A; Dent J
    Am J Physiol; 1993 Feb; 264(2 Pt 1):G195-201. PubMed ID: 8447401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absent postprandial duodenal motility in a child with cystic fibrosis. Correction of the symptoms and manometric abnormality with cisapride.
    Hyman PE
    Gastroenterology; 1986 May; 90(5 Pt 1):1274-9. PubMed ID: 2870003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of cisapride on antroduodenal co-ordination and gastric emptying.
    Johnson AG
    Scand J Gastroenterol Suppl; 1989; 165():36-43. PubMed ID: 2690323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride.
    Camilleri M; Brown ML; Malagelada JR
    Gastroenterology; 1986 Sep; 91(3):619-26. PubMed ID: 3525315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction.
    Hyman PE; Di Lorenzo C; McAdams L; Flores AF; Tomomasa T; Garvey TQ
    Am J Gastroenterol; 1993 Jun; 88(6):832-6. PubMed ID: 8503375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease.
    Maddern GJ; Jamieson GG; Myers JC; Collins PJ
    Gut; 1991 May; 32(5):470-4. PubMed ID: 2040466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cisapride: pharmacology, current therapeutic results and future prospects].
    Fraitag B; Cloarec D; Galmiche JP
    Gastroenterol Clin Biol; 1989 Mar; 13(3):265-76. PubMed ID: 2659417
    [No Abstract]   [Full Text] [Related]  

  • 14. Slow gastric emptying induced by high fat content of meal accelerated by cisapride administered rectally.
    Stacher G; Granser GV; Bergmann H; Kugi A; Stacher-Janotta G; Höbart J
    Dig Dis Sci; 1991 Sep; 36(9):1259-65. PubMed ID: 1893810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisapride in the treatment of chronic intestinal pseudo-obstruction.
    Reyntjens A; Verlinden M; Schuermans V
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():79-84; discussion 92-3. PubMed ID: 2192509
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.
    Abell TL; Camilleri M; DiMagno EP; Hench VS; Zinsmeister AR; Malagelada JR
    Dig Dis Sci; 1991 May; 36(5):616-20. PubMed ID: 2022163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cisapride on distal colonic motility in the early postoperative period following left colonic anastomosis.
    Roberts JP; Benson MJ; Rogers J; Deeks JJ; Wingate DL; Williams NS
    Dis Colon Rectum; 1995 Feb; 38(2):139-45. PubMed ID: 7851167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cisapride on gastric motility.
    Schuurkes J
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():27-30; discussion 44. PubMed ID: 2356634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antroduodenal manometry in the evaluation of chronic functional gastrointestinal symptoms.
    Hyman PE; Napolitano JA; Diego A; Patel S; Flores AF; Grill BB; Reddy SN; Garvey TQ; Tomomasa T
    Pediatrics; 1990 Jul; 86(1):39-44. PubMed ID: 2359682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in antroduodenal resistance induced by Cisapride in conscious dogs.
    Malbert CH; Serthelon JP; Dent J
    Am J Physiol; 1992 Aug; 263(2 Pt 1):G202-8. PubMed ID: 1514631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.